Prevalence of MPL W515L/K mutations in Taiwanese patients with Philadelphia-negative chronic myeloproliferative neoplasms

J Chin Med Assoc. 2010 Oct;73(10):530-2. doi: 10.1016/S1726-4901(10)70115-5.

Abstract

Background: The discovery of Janus kinase 2 (JAK2)-V617F has provided important insight into the pathogenesis of Philadelphia-negative chronic myeloproliferative neoplasms (Ph-negative MPNs); however, the etiology of JAK2(V617F)-negative Ph-negative MPN remains unidentified. MPL(W515L) and MPL(W515K) (MPL(W515L/K)) are 2 gain-of-function mutations, which have been found in some Ph-negative MPN patients from Western countries. However, little is known about the incidence of these mutations in Taiwanese Ph-negative MPN patients.

Methods: We determined the MPL sequence of DNA samples from 105 patients, including 88 patients with Ph-negative MPNs and 17 with myelodysplastic syndrome, using polymerase chain reaction amplification of the cytokine receptor MPL exon 10 sequence.

Results: All the patients were normal at codon 515 regardless of their JAK2 status.

Conclusion: The MPL W515L/K mutations are rare in Taiwanese patients with Ph-negative MPNs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chronic Disease
  • Mutation*
  • Myeloproliferative Disorders / epidemiology
  • Myeloproliferative Disorders / genetics*
  • Philadelphia Chromosome*
  • Polycythemia Vera / genetics
  • Primary Myelofibrosis / genetics
  • Receptors, Thrombopoietin / genetics*
  • Taiwan / epidemiology
  • Thrombocythemia, Essential / genetics

Substances

  • Receptors, Thrombopoietin
  • MPL protein, human